Table 1.
Baseline characteristics of study subjects used in cross-sectional and prospective analyses
Cross-sectional analyses | Prospective analyses | |
---|---|---|
Characteristic of all subjects | ||
n | 989 | 725 |
Women | 50.0 | 51.7 |
BMI ≥30 kg/m2 | 22.1 | 20.1 |
Current smokers | 10.5 | 9.0 |
Moderate or vigorous exercise | 25.1 | 28.5 |
BMI (kg/m2) | 27.0 ± 4.3 | 26.9 ± 4.0 |
Alcohol consumption (grams per week) | 6.3 ± 7.2 | 6.6 ± 7.5 |
Total cholesterol (mmol/L) | 5.3 ± 1.6 | 5.5 ± 1.0 |
Fasting triglycerides (mmol/L) | 1.3 ± 0.6 | 1.2 ± 0.6 |
Fasting blood glucose (mmol/L) | 5.3 ± 1.6 | 4.9 ± 0.5 |
Clinical features of diabetes cases* | ||
n | 112 | 36 |
Duration of diabetes (years) | 6.0 ± 6.1 | 0.7 ± 1.4 |
BMI (kg/m2) | 29.1 ± 5.3 | 29.0 ± 5.6 |
Oral antidiabetes medication | 53.6 | 30.6 |
Insulin medication | 16.1 | 11.1 |
Newly diagnosed diabetes | 43.8 | 36.1 |
Family history of diabetes | 42.5 | 38.6 |
Antihypertensive drug medication | 58.0 | 77.8 |
Statin medication | 27.7 | 36.1 |
Data are means ± SD or percent. Prospective analyses omitted prevalent diabetes at baseline as well as participants who were not followed up.
*Even though characteristics of all subjects for prospective analyses were baseline characteristics at age 70 years, clinical features of incident diabetes cases were follow-up information at age 75 years.